Drug repurposing in oncology

Lancet Oncol. 2020 Dec;21(12):e542. doi: 10.1016/S1470-2045(20)30561-1.

Authors

Gauthier Bouche¹, Craig Gedye², Lydie Meheus³, Pan Pantziarka³

Affiliations

¹ The Anticancer Fund, Strombeek-Bever 1853, Belgium. Electronic address: gauthier.bouche@anticancerfund.org.
² School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Calvary Mater Newcastle, Waratah, NSW, Australia.
³ The Anticancer Fund, Strombeek-Bever 1853, Belgium.

PMID: 33271099
DOI: 10.1016/S1470-2045(20)30561-1

No abstract available

Publication types

Letter
Comment

MeSH terms

Drug Repositioning*
Humans
Medical Oncology
Neoplasms*